Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis

Ann Rheum Dis. 2018 Nov;77(11):1610-1618. doi: 10.1136/annrheumdis-2017-212762. Epub 2018 Jul 11.

Abstract

Background: Glucocorticoid (GC) therapy is frequently used to treat rheumatoid arthritis due to potent anti-inflammatory actions of GCs. Direct actions of GCs on immune cells were suggested to suppress inflammation.

Objectives: Define the role of the glucocorticoid receptor (GR) in stromal cells for suppression of inflammatory arthritis.

Methods: Bone marrow chimeric mice lacking the GR in the hematopoietic or stromal compartment, respectively, and mice with impaired GR dimerisation (GRdim) were analysed for their response to dexamethasone (DEX, 1 mg/kg) treatment in serum transfer-induced arthritis (STIA). Joint swelling, cell infiltration (histology), cytokines, cell composition (flow cytometry) and gene expression were analysed and RNASeq of wild type and GRdim primary murine fibroblast-like synoviocytes (FLS) was performed.

Results: GR deficiency in immune cells did not impair GC-mediated suppression of STIA. In contrast, mice with GR-deficient or GR dimerisation-impaired stromal cells were resistant to GC treatment, despite efficient suppression of cytokines. Intriguingly, in mice with impaired GR function in the stromal compartment, GCs failed to stimulate non-classical, non-activated macrophages (Ly6Cneg, MHCIIneg) and associated anti-inflammatory markers CD163, CD36, AnxA1, MerTK and Axl. Mice with GR deficiency in FLS were partially resistant to GC-induced suppression of STIA. Accordingly, RNASeq analysis of DEX-treated GRdim FLS revealed a distinct gene signature indicating enhanced activity and a failure to reduce macrophage inflammatory protein (Mip)-1α and Mip-1β.

Conclusion: We report a novel anti-inflammatory mechanism of GC action that involves GR dimerisation-dependent gene regulation in non-immune stromal cells, presumably FLS. FLS control non-classical, anti-inflammatory polarisation of macrophages that contributes to suppression of inflammation in arthritis.

Keywords: arthritis; corticosteroids; fibroblasts; inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Arthritis, Experimental / drug therapy*
  • Arthritis, Experimental / metabolism
  • Arthritis, Experimental / pathology
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / metabolism
  • Arthritis, Rheumatoid / pathology
  • Cytokines / biosynthesis
  • Dexamethasone / pharmacology
  • Dexamethasone / therapeutic use*
  • Dimerization
  • Gene Expression Regulation / drug effects
  • Glucocorticoids / pharmacology
  • Glucocorticoids / therapeutic use*
  • Metabolism, Inborn Errors / metabolism
  • Metabolism, Inborn Errors / pathology
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Receptors, Glucocorticoid / deficiency
  • Receptors, Glucocorticoid / metabolism
  • Receptors, Glucocorticoid / physiology*
  • Stromal Cells / drug effects
  • Stromal Cells / metabolism*
  • Synoviocytes / drug effects
  • Synoviocytes / metabolism
  • Transplantation Chimera

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Glucocorticoids
  • Receptors, Glucocorticoid
  • Dexamethasone

Supplementary concepts

  • Glucocorticoid Receptor Deficiency